This study is aimed at evaluating vascular endothelial growth factor (VEGF) expression in the salivary glands of diabetic rats. Our study was carried out on 1 group of male Wistar rats and 1 group of male Bio Breeding Wistar (BBIW) pre-diabetic rats. The first group (control) was composed of 11 rats (4 months old), and the other (test) of 11 rats (4 months old) which showed diabetes atday 85 of life. This kind of diabetes can be compared to human . diabetes mellitus type 1. The submandibular glands were removed and processed for immunohistochemical analysis of VEGF. Diabetes increased salivary gland VEGF expression in the rats. The tissues analyzed (vascular endothelium, ductal endothelium, mucinous glands) always expressed VEGF, thus demonstrating that not only vascular endothelial cells, but also the other elements evaluated, have a role in the neoangiogenesis process. In both control and diabetic rats, the VEGF expression was constantly negative only in serous acini; thus demonstrating that serous acini are not involved in the neoangiogenetic processes. The vascular growth is a fundamental part of normal salivary gland development, therefore we speculate that strategies aimed at preservation or promotion of salivary gland VEGF expression may mitigate or attenuate diabetic-induced gland microvascular injury. Diabetes mellitus is a complex metabolic disorder to healthy participants. However, the secretory capacity characterized by hyperglycemia and the inability was markedly reduced compared to controls. These of tissues to utilize glucose. It affects many organ results indicate that diabetes mellitus can lead to a marked systems, including the oral cavity. It has been reported dysfunction of the secretary capacity of the salivary that hyperglycemia increases oxidative stress through glands. It is well known that salivary glands through their overproduction of reactive oxygen radicals (ROSs) (1-secretion products playa role in maintaining homeostasis 3). There is much evidence concerning the contribution in the oral cavity, so in patients affected by diabetes a ofROS molecules to organ injury in systems, such as the modified fluid, organic and inorganic salivary secretion heart, liver, and the central nervous system (4) (5) (6) , as well may be responsible for the increased susceptibility to oral as oxidative damage being increased in diabetes (7) . On infections (11). the other hand, it is accepted that ROSs, generated as a Abnormalities in endothelial function, such as result of hyperglycemia, play a role in many secondary increased endothelial permeability to macromolecules complications of diabetes (8) . Among the cellular effects and endothelial proliferation, may be involved in the of oxidative stress there are lipid peroxidation, DNA pathogenesis of diabetic microvascular complications oxidation, protein oxidation and deregulation of nitric (12) . Vascular endothelial growth factor (VEGF) is oxide synthesis (9) . It has been reported that the diabetic a potent cytokine and an important mediator in the state can also influence glycogen metabolism in the pathogenesis of endothelial dysfunction in diabetes (13) . submandibular and parotid salivary glands of rats (10) .
It is strongly implicated in the pathogenesis of Moreover, in a study which investigated the effects of diabetic microvascular complications due to its functions: diabetes mellitus (types I and II) on human salivary gland it increases vascular permeability to macromolecules function compared to healthy age-matched controls, the and potently stimulates the vascular endothelial cells to results showed that both type I and type II diabetic patients divide, markedly increasing monocyte chemotaxis and secrete significantly less resting and stimulated saliva tissue factor production, all of which can contribute to compared to healthy age-matched controls. It was also microvascular complications (14) (15) (16) (17) . The mechanism of found that the diabetic patients had an increased resting increased vascular permeability by VEGF may involve and stimulated salivary protein concentration compared stimulation of collagenase production and proteolytic 
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of life, the rats were anaesthetized with Nembutal (30 mg/kg) intraperitonally and then put down. The submandibular glands were removed. All specimens were immediately fixed in 10% neutral buffered formalin and then embedded in paraffin (LEICA TP1020). Three um sections were then obtained with a Leitz 1512 microtome, after which these sections were stained with Hematoxylin-Eosin (Mayer Ematossiline and Eosin G, Bio-Optica, Milano, Italy). Moreover, further 3 urn sections for each sample were obtained and put on electric charge slides.
For the immunohistochemical staining of VEGF, 3 urn sections were cut and pre-incubated in PBS for 5 min and then with rabbit polyclonal antibodies (Santa Cruz Biotech Inc, Santa Cruz, CA, USA) which were diluted I: 100 and applied for 30 minutes at room temperature. Slides were then washed twice
Fig. 1. In the vascular endothelium ofcontrol rats, low intensity (less dark) of VEGF expression is prevalent. In the vascular endothelium of test rats. it is possible to observe high intensity of VEGF expression (darker), whereas low intensity are present only in afew areas. PAP 20X
disruption of the endothelial basement membrane (18) . Antonetti et al. reported that vascular permeability in experimental diabetes is associated with reduced endothelial occludin, a tight junction protein between endothelial cells (19) (20) .
VEGF is regulated by hypoxia-mediated control of gene transcription, alternative mRNA splicing and proteolytic processing. It is important to consider the positive feedback existing between VEGF and nitric oxide (NO). NO greatly increases the effect of the VEGF, its capacity of inducing vascular permeability, and vascular dilation (21) . The production of NO is in tum regulated by the VEGF (22) (23) . This finding allows us to understand the extent to which hypoxia and hypoglycaemia can influence VEGF expression and production.
The aim of this study is to evaluate whether diabetes can damage salivary glands and influence vascular endothelial growth factor (VEGF) expression.
MATERIALS AND METHODS
Our study was carried out on one group of male Wistar rats and one group of male Bio Breeding Wistar (BB/W) pre-diabetic rats. The first group (control) was composed of II rats (4 months old) and the other (test) of II rats (4 months old) which showed diabetes at about day 85 of life. This kind of diabetes can be compared to human diabetes mellitus type I.
Urine tests were performed in order to evaluate plasma glucose and ketones which resulted positive in the diabetic rats but not in the control ones. The glycaemia levels were a mean 0008 ± 102 mg/dL in diabetic rats and 76 ± 8 mg/dL in control rats. After diabetes appeared, the BBIW rats received a low dose of insulin very slowly with a microinfusion device which was in position to release daily insulin for a month, preventing ketoacidosis, without receiving insulin exogenous. At 4 months Friedman test was used to evaluate the presence of statistically significant differences of VEGF expression between the 2 groups. The percentages have been expressed as a mean +/-standard deviation. Statistically significant differences were set at p<O.05.
RESULTS
Samples from vascular endothelium, ductal epithelium, and mucinous secreting glands demonstrating VEGF positivity were analyzed. In serous acini, in both control and test rats, the VEGF expression was constantly negative. Nervous tissue, even if positive, was not evaluated due to its scarcity.
Vascular Endothelium. Control. VEGF was found positive in 23 cases (41.8%). High intensity of expression was present in 4 vessels (7.3%), with a mean area percentage of 0.1%; low intensity of expression was found in 23 vessels (41.8%), with a mean area percentage of2.8% (Fig. I) .
Test. In diabetic rats, VEGF expression was positive in all the samples examined (100%). High intensity of expression was present in 54 vessels (98.2%), with a mean area percentage of23.3%; low intensity of expression was found in 100%, with a mean area percentage of 13.2% (Fig. I) .
VEGF showed statistically significant differences of expression in diabetic rats with regard to percentage of samples examined, intensity of expression, mean area percentage with high and low intensity of expression, mean of total area positive to VEGF (p < 0.001). (Fig. 2) .
Ductal Epithelium
Control. VEGF was found positive in 53 cases (96.4%). High intensity of expression was present in 6 vessels (10.9%), with a mean area percentage of 0.3%; low intensity of expression was found in 53 vessels (96.4%), with a mean area percentage of25.6%.
Test. VEGF expression was positive in all the sample examined (100%). High intensity of expression was present in 55 vessels (100%), with a mean area percentage of 38%; low intensity of expression was found in 100%, with a mean area percentage of 35.2%.
VEGF showed statistically significant differences of expression in diabetic rats with regard to mean of total area positive to VEGF, high intensity of expression, mean percentage of area with high intensity of expression (p < 0.001) (Fig. 3) .
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Ductal Endothelium Fig. 3 in PBS for 5 min and in Tris-HCI buffer, pH 7.6 for 10 min. Sections were incubated in the presence of biotynilated specific secondary antibody and Avidin Biotin Peroxidase was developed using diaminobenzidine chromogen (DAB) (Biomeda Corp., CA, USA) and the nuclei were counterstained with hematoxylin and coverslipped. The procedures referred to below were carried out using an automatic staining agent (Optimax Plus Bio Genex).
Quantitative analysis of VEGF expression was performed. Five random fields were chosen for each specimen and in each field an evaluation was performed after having distinguished 2 different intensities of VEGF expression, low and high which
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Mucinous Glands. Control. VEGF was found positive in 37 cases (67.3%). High intensity of expression was present in I vessel (1.8%), with a mean area percentage of 0%; low intensity of expression was found in 37 vessels (67.3%), with a mean area percentage of 0.6%.
Test. VEGF expression was positive in all the samples examined (100%). High intensity of expression was present in 55 vessels (100%), with a mean area percentage of 10.7%; low intensity of expression was found in 100%, with a mean area percentage with high and low intensity of expression of 5.8%. VEGF showed statistically significant differences of expression in diabetic rats with regard to percentage of samples examined, mean of total area positive to VEGF, intensity of expression and mean percentage of area (p < 0.001) ( Fig. 4) . DISCUSSION Diabetes implicates a series of alterations in the homeostatic mechanisms (24) . The phenomena accompanying diabetes have not yet been elucidated. Diabetes is characterized by microangiopathy, tissue hypoxia, reduction in ventilatory response to hypoxia and hypercapnia. Furthermore, diabetes is accompanied by arteriosclerosis with remodelling of capillary network and reduction in organ blood flow. Diabetes resembles, therefore, a state ofchronic hypoxia (25) . Normally, acute hypoxia inhibits enzyme activity, while in chronic hypoxia most enzymes, such as NOS and VEGF, are stimulated representing a homeostatic defence mechanism. In the present report it is demonstrated that diabetes increases salivary gland VEGF expression in rats. Moreover, all elements evaluated always expressed VEGF, thus demonstrating that not only vascular endothelial cells, but also the other elements analyzed, have a role in the neoangiogenesis process. In both control and diabetic rats, the VEGF espression was constantly negative only in serous acini; thus demonstrating that serous acini are not involved in the neoangiogenetic processes. There are no studies in literature which address the issue of diabetes influence on VEGF expression in salivary glands. It was only possible to compare results with studies which analyzed the effect of diabetes on VEGF expression in other organs. Cha et al. (13) investigated the role ofVEGF in diabetic nephropathy. It was found that urinary excretion of VEGF significantly increased according to the stage of the diabetic nephropathy. Moreover, pronounced upregulation of VEGF is found in the glomerular epithelial cells in early diabetic nephropathy, whereas a marked increase in VEGF is found in the proximal tubular cells in more advanced nephropathy. In conclusion, these results suggested that VEGF may playa role in the pathogenesis of diabetic nephropathy. Antonetti et al. (20) analyzed the effects of VEGF and diabetes on rats affected by diabetic retinopathy. Their findings suggested that the elevated VEGF levels in the vitreous of patients with diabetic retinopathy increased vascular permeability by down-regulating occludin content, and decreased tight junction protein expression may be an important means by which diabetes causes increased vascular permeability and contributes to macular oedema. In another study the same Authors (19) concluded that VEGF may have a physiologic role in regulating vessel permeability and contribute to the pathophysiology of diabetic retinopathy as well as tumour development. These findings are important for understanding the physiologic regulation of vascular permeability for normal tissue function and contribution of diabetes to the tissue oedema that results from acute inflammatory insults and chronic diseases, such as diabetic retinopathy and tumours. The results of the present study confirm in salivary glands the results already reported in other tissues. With respect to the intensity of expression, in almost all tissues examined, a high intensity of VEGF expression was prevalent in diabetic rats, and in particular the mean percentage of areas expressing high intensity of VEGF was always higher than the one expressing low intensities (Figs. 2-4) .
(S I)
The present study contributes to a better understanding of the role of VEGF in salivary glands of healthy and diabetic rats and suggests that an increased expression of VEGF may lead to altered vascular reactivity.
In conclusion, since it is evident that vascular growth is a fundamental part of normal salivary gland development, we speculate that strategies aimed at preservation or promotion of salivary gland VEGF expression may mitigate or attenuate diabetic-induced gland microvascular injury. Further studies specifically aimed at investigating these prospects as well as undertaking a comprehensive examination of the effect of O 2 and eventually NO on VEGF are warranted.
